Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETANERCEPT Cause Product substitution issue? 172 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 172 reports of Product substitution issue have been filed in association with ETANERCEPT (ENBREL). This represents 0.1% of all adverse event reports for ETANERCEPT.

172
Reports of Product substitution issue with ETANERCEPT
0.1%
of all ETANERCEPT reports
5
Deaths
21
Hospitalizations

How Dangerous Is Product substitution issue From ETANERCEPT?

Of the 172 reports, 5 (2.9%) resulted in death, 21 (12.2%) required hospitalization, and 4 (2.3%) were considered life-threatening.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ETANERCEPT. However, 172 reports have been filed with the FAERS database.

What Other Side Effects Does ETANERCEPT Cause?

Drug ineffective (60,367) Rheumatoid arthritis (33,166) Pain (31,961) Arthralgia (27,429) Injection site pain (24,717) Off label use (20,178) Fatigue (19,907) Joint swelling (18,462) Injection site erythema (17,736) Condition aggravated (15,897)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which ETANERCEPT Alternatives Have Lower Product substitution issue Risk?

ETANERCEPT vs ETANERCEPT-SZZS ETANERCEPT vs ETELCALCETIDE ETANERCEPT vs ETEPLIRSEN ETANERCEPT vs ETESEVIMAB ETANERCEPT vs ETHACRYNIC ACID

Related Pages

ETANERCEPT Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue ETANERCEPT Demographics